General
Preferred name
IDAZOXAN
Synonyms
IDAZOXAN HYDROCHLORIDE ()
RX 781094 ()
Idazoxan (hydrochloride) ()
RX 781094 (hydrochloride) ()
Idazoxan HCl ()
NSC-759867 ()
Racemic idazoxan ()
Dl-idazoxan ()
RX-781094 ()
P&D ID
PD013324
CAS
79944-58-4
79944-56-2
90755-83-2
Tags
drug candidate
natural product
available
Drug indication
Neurological disorder
Drug Status
investigational
Max Phase
Phase 3
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Idazoxan has α2-adrenoceptor antagonist activity.
(GtoPdb)
DESCRIPTION
I2-imidazoline agonist; I1-imidazoline antagonist; alpha2-Adrenergic antagonist
(LOPAC library)
DESCRIPTION
Selective and irreversible kappa antagonist
(Tocris Bioactive Compound Library)
DESCRIPTION
α2 antagonist. Also I2 ligand
(Tocriscreen Total)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
3
Compound Sets
16
ChEMBL Drugs
Concise Guide to Pharmacology 2023/24
DrugBank
DrugMAP
DrugMatrix
Guide to Pharmacology
Ki Database
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Total
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
37
Properties
(calculated by RDKit )
Molecular Weight
204.09
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
1
Ring Count
3
Aromatic Ring Count
1
cLogP
0.83
TPSA
42.85
Fraction CSP3
0.36
Chiral centers
1.0
Largest ring
6.0
QED
0.74
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
I1 / I2
Pathway
Neuroscience
GPCR/G protein
Neuronal Signaling
Target
Adrenergic Receptor
Imidazoline Receptor
Primary Target
Adrenergic ?2 Receptors
MOA
Antagonist
Source data